Top 50 Life Science VC Funds & Investors in Middle East (August 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
TRANGELS
VC Fund
|
6 | Turkey, United States, Estonia | Seed, Pre-Seed, Angel | Software, Information Technology, Artificial Intelligence | $29k–$1.4M |
|
Israel Innovation Authority
VC Fund
|
6 | Israel, United States, Mali | Grant, Seed, Pre-Seed | Health Care, Artificial Intelligence, Biotechnology | $130k–$5M |
|
Egypt Ventures
VC Fund
|
5 | Egypt, United States, The Netherlands | Seed, Venture - Series Unknown, Pre-Seed | Software, Information Technology, FinTech | $28k–$120M |
|
Sapir Venture Partners
VC Fund
|
4 | Israel, United States, United Kingdom | Seed, Pre-Seed, Series A | Software, Biotechnology, Analytics | $1.3M–$40M |
|
Integra Holdings
VC Fund
|
4 | Israel | Seed, Series B, Series F | Biotechnology, Pharmaceutical, Life Science | |
|
aMoon Fund
VC Fund
|
4 | United States, Israel, France | Series B, Series A, Series C | Health Care, Biotechnology, Medical | $5.7M–$93M |
|
Pitango VC
VC Fund
|
3 | Israel, United States, China | Series B, Series A, Series C | Software, Health Care, Information Technology | $4M–$100M |
|
OrbiMed
VC Fund
|
3 | United States, China, Israel | Series B, Series A, Series C | Biotechnology, Health Care, Medical | $10M–$183M |
|
Grove Ventures
VC Fund
|
3 | Israel, United States | Seed, Series A, Series B | Artificial Intelligence, Software, Machine Learning | $3.5M–$74M |
|
FutuRx
VC Fund
|
3 | Israel | Seed | Biotechnology, Life Science, Biopharma | |
|
Neo Ventures
VC Fund
|
3 | United States, United Kingdom, Israel | Seed, Series A | Software, Artificial Intelligence, SaaS | $500k–$24M |
|
Acasia Group
VC Fund
|
3 | Egypt, United States, Nigeria | Seed, Angel, Venture - Series Unknown | E-Commerce, Financial Services, Mobile | $50k–$2.6M |
|
PeakBridge
VC Fund
|
2 | Israel, United States, United Kingdom | Series A, Seed, Series B | Food and Beverage, Health Care, Food Processing | $501k–$50M |
|
Annex Investments
VC Fund
|
2 | United Arab Emirates, Oman, Saudi Arabia | Seed, Pre-Seed, Series A | Information Technology, Software, Artificial Intelligence | $100k–$6.5M |
|
Cancer Focus Fund
VC Fund
|
2 | Israel, United States, Germany | Venture - Series Unknown, Series A, Seed | Biotechnology, Medical, Health Care | $4.5M–$47M |
|
Takeda Ventures
VC Fund
|
2 | United States, United Kingdom, Israel | Series A, Series B | Biotechnology, Health Care, Therapeutics | $10M–$130M |
|
Alex Angels
VC Fund
|
2 | Egypt, Denmark, The Netherlands | Seed, Pre-Seed, Convertible Note | E-Commerce, Logistics, Food and Beverage | $28k–$1.6M |
|
Minrav
VC Fund
|
2 | Israel, Malaysia | Series A | Health Care, Hospital, Wellness | $10M–$10M |
|
fresh.fund
VC Fund
|
2 | Israel, United States, Norway | Seed, Pre-Seed, Series A | Health Care, Artificial Intelligence, Software | $300k–$21M |
|
LoftyInc Capital
VC Fund
|
2 | United States, Nigeria, Egypt | Seed, Pre-Seed, Venture - Series Unknown | Financial Services, FinTech, Software | $100k–$10M |
|
SOSV
VC Fund
|
2 | United States, India, United Kingdom | Seed, Convertible Note, Pre-Seed | Biotechnology, Health Care, Software | |
|
Genesis Park
VC Fund
|
2 | United States, Israel | Private Equity, Debt Financing | Health Care, Construction, Manufacturing | $2.5M–$200M |
|
Hult Alumni Angels
VC Fund
|
2 | Egypt | Seed, Debt Financing | Biopharma, Life Science, Biotechnology | |
|
Oryx Fund
VC Fund
|
2 | United Arab Emirates, Saudi Arabia, Oman | Seed, Pre-Seed, Series A | Software, SaaS, FinTech | $1000k–$13M |
|
Arancia International
VC Fund
|
2 | Israel, United States, Malaysia | Series A, Series B | Health Care, Biotechnology, Life Science | $7.5M–$17M |
|
Alexandria Fund
VC Fund
|
2 | Egypt | Seed, Debt Financing | Biopharma, Life Science, Biotechnology | |
|
First Star Ventures
VC Fund
|
2 | United States, Canada, Israel | Seed, Pre-Seed, Series A | Software, Artificial Intelligence, Biotechnology | $575k–$15M |
|
Jerusalem Venture Partners (JVP)
VC Fund
|
2 | United States, Israel, United Kingdom | Series A, Series B, Seed | Software, Cyber Security, Enterprise Software | $1.5M–$43M |
|
Johnson & Johnson Robotics and Digital Solutions
VC Fund
|
2 | United States, Israel, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $300k–$100M |
|
RMGP Biopharma Investment Fund
VC Fund
|
2 | Israel | Seed, Series B | Biotechnology, Biopharma, Life Science | |
|
Ibtikar Fund
VC Fund
|
2 | Palestinian Territory, United States, Jordan | Seed, Pre-Seed, Series A | Software, Artificial Intelligence, SaaS | $60k–$2M |
|
Pontifax
VC Fund
|
2 | United States, Israel, France | Series A, Series B, Series C | Biotechnology, Health Care, Pharmaceutical | $6.3M–$130M |
|
Grok Ventures
VC Fund
|
2 | Australia, United States, Singapore | Series A, Seed, Series B | Renewable Energy, Energy, Software | $808k–$151M |
|
Keiretsu Forum
VC Fund
|
1 | United States, India, Turkey | Seed, Series A | Health Care, Software, Biotechnology | $85k–$10M |
|
TÜBİTAK
VC Fund
|
1 | Turkey, United States, United Kingdom | Grant, Pre-Seed, Seed | Software, Artificial Intelligence, Health Care | $4k–$521k |
|
Trust Ventures
VC Fund
|
1 | United States, Brazil, Israel | Seed, Series A, Series B | Health Care, Software, Information Technology | $3.2M–$200M |
|
Rationalwave Capital Partners
VC Fund
|
1 | United States, Israel, Trinidad and Tobago | Seed, Pre-Seed | Analytics, Machine Learning, Artificial Intelligence | $1.3M–$8.8M |
|
Joa Capital
VC Fund
|
1 | United Arab Emirates, Saudi Arabia, Kuwait | Seed, Series A, Pre-Seed | FinTech, Information Technology, Apps | |
|
Sectoral Asset Management
VC Fund
|
1 | United States, United Kingdom, France | Series B, Series C, Post-IPO Equity | Biotechnology, Health Care, Medical | |
|
Clal Biotechnology Industries
VC Fund
|
1 | Israel, United States | Series A, Series B | Health Care, Biotechnology, Medical | $4M–$55M |
|
Angel
VC Fund
|
1 | United States, United Kingdom, Singapore | Pre-Seed, Seed, Series A | Software, Information Technology, Artificial Intelligence | |
|
Milk and Honey Investments
VC Fund
|
1 | Israel | Series A | Life Science, Organic Food, Biotechnology | |
|
Stony Hill Corp
VC Fund
|
1 | Israel | Series A | AgTech, Medical, Cannabis | |
|
Arba Finance Ltd.
VC Fund
|
1 | Israel | Series A | AgTech, Medical, Cannabis | |
|
HBL Hadasit Bio Holdings
VC Fund
|
1 | Israel | Series A, Series B | Biotechnology, Medical, Health Care | |
|
Boehringer Ingelheim Venture Fund
VC Fund
|
1 | United States, Germany, Switzerland | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | $1.8M–$50M |
|
Khwarizmi Ventures
VC Fund
|
1 | Saudi Arabia, United Arab Emirates, Egypt | Seed, Series A, Pre-Seed | E-Commerce, Software, FinTech | |
|
Knuru Capital
VC Fund
|
1 | United Arab Emirates, Spain, Kenya | Series A, Series C | E-Commerce, Information Technology, Financial Services | |
|
Pfizer
VC Fund
|
1 | United States, Israel, France | Post-IPO Equity, Series A, Seed | Biotechnology, Health Care, Pharmaceutical | |
|
Khosla Ventures
VC Fund
|
1 | United States, India, United Kingdom | Series A, Series B, Seed | Software, Artificial Intelligence, Health Care | |
| Access all 50 VC funds in Middle East Life Science startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Early Stage Investment Fund and Network
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Pre-Seed, Angel
- Geography: Turkey, United States, Estonia
Investor stats
- Total investments: 59
- Round size: Seed $67k–$1.4M; Angel $100k–$500k; Pre-Seed $29k–$500k
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- Zippsi — Zippsi connects individual and corporate clients with vehicle leasing companies in a quick, efficient and smart way.
- Trawell Data — Trawell Data is a mobile data services company that provides travelers to use mobile data on their mobile phones without changing phones or sim cards. It enables the phone to digitally connect and use the local operator. Trawell Data was established in 2015 and is headquartered in Syosset, New York.
- Visionteractive — Visionteractive develops social media based, fun and interactive physical and digital products, bridging the gap between online and actual world. The company aims to bring a brand together with the target audience by developing various creative products, while enhancing the memorability owing to the interactive experience with the users.Visionteractive was founded on 2013 and is based in Turkey.
The Israel Innovation Agency, the Innovation Authority, was established in 1965 as the Office of the Chief Scientist of the Ministry of Industry and Trade and was designed as a body that supports R & D conducted in the framework of government research institutes. Industrial development in order to increase industrial exports of high-techproducts. The Chief Scientist focused on reducing the risk by participating in financing the project, which the private companies chose and led.
Show more...Investment focus
- Industry: Health Care, Artificial Intelligence, Biotechnology
- Stage:Grant, Seed, Pre-Seed
- Geography: Israel, United States, Mali
Investor stats
- Total investments: 200
- Round size: Seed $500k–$5M; Grant $130k–$3.5M; Pre-Seed $150k–$2.1M
- Lead/follow: 48% lead, 52% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Brevel — Brevel developed a disruptive cultivation technology for sustainable, low cost and high quality production of microalgae for various yet untapped markets. The technology is based on high-tech indoor, sterile and fully automated systems which are illuminated from within at high intensity. The technology enables the surprising results of more than90% cost reduction and up to 200 higher yields compared to current alternatives. Brevel is using the advantageous production capabilities to enter multiple markets where microalgae derived products are needed.
- NanoGhosts — NanoGhosts’ technology is based on its founder’s research, that the Technion's commercial unit has patented in the U.S. and Europe.
- GeoRank Studio — Get your business ranked on Google, cited by ChatGPT & Perplexity, and protected from reputation damage. Specialist SEO and GEO agency. Free consultation.
Egypt Ventures is an investment firm that empowers the entrepreneurial ecosystem by investing in accelerators. The firm was founded in 2017 and is based in Columbia.
Show more...Investment focus
- Industry: Software, Information Technology, FinTech
- Stage:Seed, Venture - Series Unknown, Pre-Seed
- Geography: Egypt, United States, The Netherlands
Investor stats
- Total investments: 38
- Round size: Seed $100k–$3M; Pre-Seed $28k–$2M; Venture - Series Unknown $3.2M–$120M
- Lead/follow: 32% lead, 68% follow
Portfolio highlights
- Flend — Egypt’s first tech enabled, data driven financing solutions platform dedicated to small businesses.
- D OCC Hub — Smart Incident Management Solutions
- InfiniLink — Empowering Hyperscale Datacenters Building Energy-Efficient Ultra-High-Speed Connectivity Solutions
Early Stage VC
Show more...Investment focus
- Industry: Software, Biotechnology, Analytics
- Stage:Seed, Pre-Seed, Series A
- Geography: Israel, United States, United Kingdom
Investor stats
- Total investments: 21
- Round size: Seed $1.3M–$10M; Series A $10M–$40M
- Lead/follow: 19% lead, 81% follow
Portfolio highlights
- Enzymit — Enzymit's platform technology can build molecular machines that enable never before seen chemistry aiming to solve humanity's greatest challenges
- Lidwave — Lidwave’s deep-tech solution revolutionizes 3D sensing and the verticals relying on it by examining the biggest challenge in LiDAR technology from a new perspective, free of bandwidth limitations.
- DeepCure — DeepCure is a Boston-based therapeutics company that harnesses advanced AI, physics-based tools and automation to discover novel small molecules for challenging targets. DeepCure currently has a lead asset in IND-enabling studies and other programs focused on drugging intractable targets that have t
Our expert team is the first to examine and evaluate the Hebrew University's biomedical breakthroughs. We then capitalize decades of experience - transforming the inventions into pioneering companies. Our golden eggs Ayana Pharma A late stage company with
Show more...Investment focus
- Industry: Biotechnology, Pharmaceutical, Life Science
- Stage:Seed, Series B, Series F
- Geography: Israel
Investor stats
- Total investments: 8
- Lead/follow: 75% lead, 25% follow
Portfolio highlights
- BacoCure — BacoCure is developing a novel bacterial product for local therapy of non-muscle invasive bladder cancer (NMIBC) patients.
- Splisense — Transformative RNA Based Treatments -Antisense Oligonucleotides- Targeting the Root Cause of Pulmonary Diseases Our innovative RNA based therapies, based on Antisense Oligonucleotides (ASOs), restore and modify protein functionality, addressing untreatable pulmonary diseases.
- Rebiotic Rx — Develops nanotechnology-based antibiotics with the focus on resistant bacteria
aMoon is a leading healthtech & life sciences venture fund founded by Marius Nacht and Dr. Yair Schindel. Their team is passionate about building successful businesses and helping biopharma, digital health and medical technology companies realize their potential. They partner with management teams who use technology and cutting-edge science toaccelerate cures for the world’s most life-threatening conditions and those providing solutions for global healthcare’s biggest cost drivers.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series B, Series A, Series C
- Geography: United States, Israel, France
Investor stats
- Total investments: 79
- Round size: Series A $5.7M–$82M; Series B $22M–$93M; Series C $30M–$82M
- Lead/follow: 49% lead, 51% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Adcytherix — Adcytherix is a biopharmaceutical company focused on the development of novel antibody drug conjugates (ADC) to treat high unmet need diseases such as cancer.
- Lin Health — Online chronic pain recovery program designed to get you back to the life you want to live. One-on-one coaching. Real pain reduction results.
- Connie Health — At Connie Health, our Medicare advisors help older Americans find the right Medicare plan - all at no cost to you.
Pitango VC is a venture capital firm focused on health-tech (Pitango Health-tech) and growth (Pitango Growth) investments in startups around the world in domains such as vertical SaaS, digital health, deep tech, fintech and insurance technology, devops, generative AI, Web3, and food tech.With two offices in Israel, Pitango currently managesseveral venture funds totaling over $2.8 billion in committed capital. It has invested in more than 250 companies.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Series B, Series A, Series C
- Geography: Israel, United States, China
Investor stats
- Total investments: 301
- Round size: Series A $4M–$50M; Series B $8.1M–$55M; Series C $8.2M–$100M
- Lead/follow: 35% lead, 65% follow
- Last fund: Likely still investing — raised $175M in 2023
Portfolio highlights
- Convizit — Convizit's AI automatically captures user actions, adds properties, and delivers this behavioral data directly into your analytics and marketing platforms.
- Connie Health — At Connie Health, our Medicare advisors help older Americans find the right Medicare plan - all at no cost to you.
- QuantHealth — QuantHealth is an AI company that provides a platform to simulate clinical trials in order to accelerate and de-risk drug development.
Leading Global Healthcare Platform with Deep Proprietary Resources and Global Industry Coverage.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A, Series C
- Geography: United States, China, Israel
Investor stats
- Total investments: 653
- Round size: Series A $10M–$150M; Series B $24M–$150M; Series C $18M–$183M
- Lead/follow: 35% lead, 65% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- CardiAQ Valve Technologies — CardiAQ Valve Technologies (CVT), a privately held company, is developing innovative approaches to heart valve replacement and is initially focused on transcatheter mitral valve implantation (TMVI).
- Sonendo — Sonendo developing innovative technologies to transform dentistry by Saving Teeth Through Sound Science®. The GentleWave® System shows significant improvements in clinical efficacy and practice efficiency when compared to standard root canal treatment.1,2, 3 Sonendo is the parent company of TDO® Software, the developer of the most widely usedendodontic practice management software in the world, designed to simplify practice workflow. TDO software seamlessly integrates practice management, imaging, social media, referral reporting, CBCT imaging, and offers built-in communication with the GentleWave System.
- Acceleron Pharma — At Merck, we're following the science to tackle some of the world's greatest health threats. Get a glimpse of how we work to improve lives.
Grove Ventures is a leading early-stage venture capital fund in Israel. It partners with seed and early-stage founders
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Machine Learning
- Stage:Seed, Series A, Series B
- Geography: Israel, United States
Investor stats
- Total investments: 73
- Round size: Seed $3.5M–$20M; Series A $8M–$50M; Series B $20M–$74M
- Lead/follow: 41% lead, 59% follow
- Last fund: Likely still investing — raised $185M in 2022
Portfolio highlights
- LimitlessCNC — Limitless CNC is an AI-powered technology intended to improve CNC machining operations. It offers an AI CAM agent that works with NX-CAM to give industry-specific strategies and operations.
- Scala Biodesign — At Scala Biodesign, we provide our partners a unique one-shot computational protein design solutions to dramatically increase the value and accelerate the development of proteins into commercial products.
- FormX — California's trusted sustainable builders. FormX delivers fully customized single-family homes, ADUs, and backyard offices built faster with component-based modular construction.
FutuRx is the Israeli biotechnology accelerator that was established in 2014 by OrbiMed Israel Partners, Johnson & Johnson Innovation and Johnson & Johnson Development Corporation (JJDC) and Takeda Ventures Inc. following winning the tender of the Office of the Chief Scientist (OCS), Ministry of Economy, in Israel.The incubator willadvance new biotechnology products by identifying and nurturing early-stage life science innovation.FutuRx is located in the Weizmann Science Park in Ness Ziona (near the Weizmann Institute), Israel.
Show more...Investment focus
- Industry: Biotechnology, Life Science, Biopharma
- Stage:Seed
- Geography: Israel
Investor stats
- Total investments: 4
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Skip Therapeutics — Skip Therapeutics develops precision, RNA-based, treatments for rare genetic diseases. Millions of people worldwide are affected by thousands of rare genetic disorders, yet the limited patient populations, further divided by patient-specific mutations, have hampered the discovery of effective treatments. Recent developments in RNA-therapeuticsprovide an enlarged molecular toolkit that can be used quickly and affordably to repair damaged genes' ability to make proteins. Computational techniques could be used to help identify sub-patient populations that would be eligible for treatment with RNA-based therapeutics and match molecular therapy options across the large landscape of known disease-causing mutations.
- Protekt Therapeutics — ProteKt Therapeutics is a drug development company aiming to develop potent and selective oral inhibitors of the kinase PKR for the treatment of neurodegenerative and neuroinflammatory diseases. The company has raised a $4M pre-A round and graduated from the FutuRx accelerator in 2019.
- Bsense Bio Therapeutics — Bsense Bio Therapeutics develops small molecules for the treatment of sensory hyperexcitability related disorders. Bsense pioneers a novel approach targeting multiple hyperexcitability-related mechanisms using a single compound, to achieve greater efficacy and safety.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Neo Ventures is a venture capital investment platform focused on deep tech, funds and high-growth startup portfolio.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, SaaS
- Stage:Seed, Series A
- Geography: United States, United Kingdom, Israel
Investor stats
- Total investments: 18
- Round size: Seed $500k–$2.9M; Series A $2.3M–$24M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Bulbi — Bulbi is a child development platform designed to help parents discover online and face-to-face educational activities for their children.
- Convex — All gas, no breakages. Convex is the reactive backend platform that keeps up with you and your agents.
- Extend Robotics — Extend Human Capabilities Beyond Physical Presence
Cairo Angels is an angel investment network that invests in and supports early-stage startups it convenes regular investment meetings to review pre-selected potential investees.
Show more...Investment focus
- Industry: E-Commerce, Financial Services, Mobile
- Stage:Seed, Angel, Venture - Series Unknown
- Geography: Egypt, United States, Nigeria
Investor stats
- Total investments: 39
- Round size: Seed $50k–$2.6M; Angel $200k–$300k
- Lead/follow: 36% lead, 64% follow
Portfolio highlights
- Bosta — Bosta provides an on-demand courier app with a B2C focus, allowing users to send parcels to their customers. The platform connects its users to couriers and allows them to monitor the status of the delivery of the package. Bosta was founded in 2017 and is headquartered in Cairo, Al Qahirah, Egypt.
- EFG EV Fintech — EFG EV Fintech is investing in startups and bolstering the Fintech ecosystem in the process. EFG EV Fintech combines the financial know-how of EFG Hermes and entrepreneurial expertise of Egypt Ventures to launch the a Fintech-focused startup accelerator.They invest in rising Fintech startups with the potential to grow domestically and expandbeyond the Egyptian market. EFG EV Fintech also provides innovators with the fully integrated services they need to thrive – from funding to mentorship, to training, and office space.
- Tagaddod — Tagaddod is a renewable Energy and Waste Management Egyptian company, started in February 2013 and operating in Cairo –Egypt. Currently focusing on clean fuels, Tagaddod is working on Biodiesel production from Vegetable Oils. Biodiesel is a fuel alternative that is produced from waste vegetable oils and used in conventional diesel engines, whichcan directly substitute for or extend supplies of traditional petroleum diesel.
PeakBridge is a highly networked, global impact VC that funds and connects the people, technology and processes that will shape the future of food. We invest in visionary pioneers, from early stage to Series A-B, with scalable, protectable climate and health-focused technologies. At their core: a deep commitment to disrupting our food system whiledriving positive impact. Our team is spread across seven countries and includes pioneers of FoodTech investment and decades of deep Agri-Food operational and financial experience. Together, we create exceptional value for bold FoodTech entrepreneurs and investors. A member of the Edmond de Rothschild Private Equity partnership, PeakBridge is also the only venture capital firm that is an official partner of the world’s largest Agri-Food innovation initiative, EIT Food.
Show more...Investment focus
- Industry: Food and Beverage, Health Care, Food Processing
- Stage:Series A, Seed, Series B
- Geography: Israel, United States, United Kingdom
Investor stats
- Total investments: 56
- Round size: Seed $501k–$11M; Series A $4.5M–$17M; Series B $11M–$50M
- Lead/follow: 50% lead, 50% follow
- Last fund: Likely still investing — raised $106M in 2022
Portfolio highlights
- Myota — Precision prebiotic products developed by gut microbiome scientists. Clinically proven to improve your mental and physical health, and patented.
- Ilant Health — We offer a comprehensive solution that take the stress and stigma out of obesity treatment. We increase access, improve quality, and drive reduction in total cost of care.
- KÄÄPÄ Biotech — Medicinal mushrooms, biotechnology, mycology, forestry, agroforestry, and food production.
Annex Investments is a Multifaceted Hybrid Venture Single-Family Office, (Located in Abu Dhabi, United Arab Emirates), strategically blending the patient capital and long-term vision of a traditional SFO with the dynamic, high-growth strategies of a venture firm. We actively build businesses, forge strategic partnerships, and shape the future ofthe MENA business landscape. Our integrated approach is built upon four core pillars: Venture Capital, Joint Ventures/Strategic Partnerships, a proprietary Venture Studio and comprehensive Market Entry & Advisory services
Show more...Investment focus
- Industry: Information Technology, Software, Artificial Intelligence
- Stage:Seed, Pre-Seed, Series A
- Geography: United Arab Emirates, Oman, Saudi Arabia
Investor stats
- Total investments: 15
- Round size: Seed $1M–$6.5M; Pre-Seed $100k–$2M
- Lead/follow: 7% lead, 93% follow
Portfolio highlights
- Ovasave — Understnd your fertility & hormonal health with Ovasave. Affordable & science-backed care to protect your future fertility. Egg freezing packages. Subscribe now!
- eMushrif — You no longer have to compromise on your child's safety on school transportation.
- Keyper — Keyper simplifies real estate management for property owners, tenants, and partners. Manage portfolios, get market insights, apply for rent with flexible payment options, and explore partnership opportunities to earn passive income. Join Keyper today!
Cancer Focus Fund is an oncology-focused investment firm advancing breakthrough cancer therapies by partnering with leading scientists, institutions and early-stage companies.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Venture - Series Unknown, Series A, Seed
- Geography: Israel, United States, Germany
Investor stats
- Total investments: 10
- Round size: Series A $5.4M–$28M; Venture - Series Unknown $4.5M–$47M
- Lead/follow: 60% lead, 40% follow
- Last fund: May invest from a new fund soon — raised $50M in 2019
Portfolio highlights
- KAHR medical — KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment optionsfor cancer and autoimmune disorders.
- March Biosciences — Transforming Patient Care by Unlocking New Target Spaces march.biosciences is a clinical-stage company in the cell therapy field focused on developing CAR-T cell strategies to address the most challenging hematological cancers Pipeline MB-105 https://march.bio/wp-content/uploads/2023/05/shutterstock_1008023995-HD-30.mp4 Focused on Excellence Target Space Our approach combines biological and engineering insights to enable target-unlock without the risk and complexity of
- Starget Pharma — Starget Pharma develops a new generation of targeted radiopharmaceutical technologies for the treatment of solid tumors. Starget Pharma has a pipeline of novel targeted radiopharmaceutical molecules that act as a vector for selectively transferring radioisotopes to cancer tumor tissues.
Takeda Ventures, Inc. (TVI) is the corporate investment arm of Takeda Pharmaceutical Company Limited (TPC). TVI was founded in 2001 and invests in current and future areas of interest for TPC. They are based alongside Takeda’s R&D sites in Cambridge, MA, and San Diego, CA. As a strategic investor, TVI aims to provide support and guidance toentrepreneurs and early-stage companies driving concepts through clinical proof of concept. They also strive to forge active, collaborative interactions that result in synergies with Takeda's considerable R&D resources. Their goal is to build a portfolio of strategic investments, with an immediate emphasis on oncology, gastroenterology, neuroscience, and rare diseases.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B
- Geography: United States, United Kingdom, Israel
Investor stats
- Total investments: 104
- Round size: Series A $10M–$58M; Series B $20M–$130M
- Lead/follow: 18% lead, 82% follow
Portfolio highlights
- Integra Therapeutics — Integra Therapeutics is a developer of next generation of gene editing tools to cure diseases.
- Accipiter Biosciences — Accipiter Biosciences is a biotechnology company.
- Harness Therapeutics — Transine Therapeutics is a private biotechnology company focused on the development of a novel class of therapeutic RNAs that can upregulate protein expression with an unprecedented level of control and specificity: the SINEUPs®. The company's pioneering technology is expected to offer an entirely unique mechanism of action for currentlyhard-to-treat diseases by massively extending the druggable proteome and allowing it to address diseases that have been beyond the reach of small molecules, conventional biologics, or gene therapies.
Alexandria Business Angels Network
Show more...Investment focus
- Industry: E-Commerce, Logistics, Food and Beverage
- Stage:Seed, Pre-Seed, Convertible Note
- Geography: Egypt, Denmark, The Netherlands
Investor stats
- Total investments: 31
- Round size: Seed $100k–$1.2M; Pre-Seed $28k–$1.6M
- Lead/follow: 45% lead, 55% follow
- Last fund: May invest from a new fund soon — raised $1.9M in 2020
Portfolio highlights
- Suplyd — Suplyd is a comprehensive digital solution that bridges the gap between restaurant operators and their suppliers in order to disrupt an untouched market with extreme fragmentation and resolve the problem end-to-end.
- AgriCash — AgriCash is 1st AgriFinTech app Provides PNPL service for the agricultural sector in Egypt
- Poultry Sync — Take your poultry production operation to the next level and leverage artificial intelligence to boost performance, save cost, control fraud, and increase efficiency.
Minrav provides engineering and construction services.
Show more...Investment focus
- Industry: Health Care, Hospital, Wellness
- Stage:Series A
- Geography: Israel, Malaysia
Investor stats
- Total investments: 4
- Round size: Series A $10M–$10M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- iwi Life — Algae is the ultimate source of Omega-3s. Research has proven that Omega-3s support cardiovascular health, a balanced mood, and healthy brain development.
- Qualitas Health — Qualitas Health Group aims to serve patients through a network of 500 clinics by 2022 with quality healthcare services across the Asia Pacific.
fresh.fund is an Israeli pre-seed venture capital fund investing in early-stage startups across segments and verticals.We're built to partner with early-stage founders from day one, often as the company's first institutional investors. Our model is refreshingly simple: up to $300,000 in pre-seed funding within <4 weeks and follow-oncapital as necessary.Check out our portfolio here >> https://www.fresh.fund/portfolio. It's never too early to have a conversation about your startup.
Show more...Investment focus
- Industry: Health Care, Artificial Intelligence, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: Israel, United States, Norway
Investor stats
- Total investments: 44
- Round size: Seed $1.6M–$10M; Pre-Seed $300k–$6M; Series A $11M–$21M
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- Kimba — Kimba is the first sleep system that reads your body and responds to it silently and automatically every night, using the only sensory pathway that can reach a sleeping brain. Reserve your Kimba today!
- CopilotKit — The Enterprise-Ready Frontend Stack for Agents. CopilotKit lets you integrate LLMs or agents with real-time context, UI control, and full flexibility.
- Shifters AI — Shifters builds autonomous robotic teams for dangerous ground missions.
LoftyInc Capital Management empowers Afropreneurs to build a prosperous and equitable future in Africa. We deliver value to both founders and investors.........
Show more...Investment focus
- Industry: Financial Services, FinTech, Software
- Stage:Seed, Pre-Seed, Venture - Series Unknown
- Geography: United States, Nigeria, Egypt
Investor stats
- Total investments: 170
- Round size: Seed $100k–$5M; Pre-Seed $100k–$2.4M; Venture - Series Unknown $200k–$10M
- Lead/follow: 13% lead, 87% follow
- Last fund: Likely still investing — raised $14M in 2021
Portfolio highlights
- Cauridor — Cauridor is a Financial Services company.
- WafR — WafR is a reward-based loyalty startup that allows users to earn phone recharges while shopping at retail shops.
- Nucleon Security — Zero-Trust and ML-based Endpoint Detection and Response Platform #EDR #FDR #EndpointSecurity
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Convertible Note, Pre-Seed
- Geography: United States, India, United Kingdom
Investor stats
- Total investments: 1482
- Lead/follow: no public data
Portfolio highlights
- MixRift — MIXRIFT - game developers specialized in Mixed Reality
- unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
- Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
Genesis Park is a Houston-based private equity firm focusing on buyouts, partnering strategies with public corporations, and growth financing. We bring capital, commercial execution capabilities and a depth of experience in mergers and acquisitions.We are opportunistic within market sectors where we have depth and exposure. Those sectors includetelecommunications, energy technology and media. Energy technology is a rapidly expanding category, and our Houston base allows us to marry traditional and alternative techniques in upstream and downstream environments. Founded in 2000, Genesis Park has used discipline and patience to build value for our investors, regardless of prevailing market conditions. We are consistently active in our portfolio companies, listening, learning and adding value by working alongside management. While our preference is to partner with an existing management team, we commonly source additional talent to optimize the existing opportunity.
Show more...Investment focus
- Industry: Health Care, Construction, Manufacturing
- Stage:Private Equity, Debt Financing
- Geography: United States, Israel
Investor stats
- Total investments: 24
- Round size: Debt Financing $5.5M–$65M; Private Equity $2.5M–$200M
- Lead/follow: 54% lead, 46% follow
- Last fund: Likely still investing — raised $275M in 2021
Portfolio highlights
- Procare Ambulance — Official Twitter account of Procare Ambulance of Maryland.
- T&R Recovery Group — Founded in 2022 by Thomas Isbell and Roy M. Serpa, T&R Recovery Group is committed to revolutionizing the landscape of trauma, addiction, and mental
- GLASS BOX TECHNOLOGY INC — Glass Box Technology Inc offers customizable network, storage, security, and server solutions designed to meet the needs of the industries.
Hult Alumni Angels
Show more...Investment focus
- Industry: Biopharma, Life Science, Biotechnology
- Stage:Seed, Debt Financing
- Geography: Egypt
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Nawah Scientific — Nawah is MENA & Africa's first Cloud Lab providing R&D services to the region's scientific sectors.
Oryx Fund is a MENA-focused Investment fund from Hambro Perks. Investing in game-changing early-stage technology companies at late Seed and Series A, led by outstanding entrepreneurs in sectors we have deep expertise such as Fintech, Healthtech, Enterprise tech, Logistics tech, and Edtech.
Show more...Investment focus
- Industry: Software, SaaS, FinTech
- Stage:Seed, Pre-Seed, Series A
- Geography: United Arab Emirates, Saudi Arabia, Oman
Investor stats
- Total investments: 31
- Round size: Seed $1M–$6.5M; Pre-Seed $1000k–$2.2M; Series A $5M–$13M
- Lead/follow: 45% lead, 55% follow
Portfolio highlights
- Armoir — Armoir is a luxury luggage brand that designs quality suitcases inspired by travel trunks.
- Coraly — Coraly helps real estate teams create listing-ready content, qualify leads, manage transactions, and share client-ready Packs from one AI-powered platform.
- Qanooni — The legal AI operating system for law firms. Qanooni connects your matters, precedents and 5,000+ cited legal authorities, inside Word and Outlook.
Arancia International Inc is a part of Arancia Group in Mexico. We are long term investors in food, nutrition and biotechnology companies.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Life Science
- Stage:Series A, Series B
- Geography: Israel, United States, Malaysia
Investor stats
- Total investments: 9
- Round size: Series A $10M–$17M; Series B $7.5M–$11M
- Lead/follow: 22% lead, 78% follow
Portfolio highlights
- NextFerm — NextFerm is a science oriented industrial company, representing a new era in fermentation and fermentation-derived nutrients for supplements, food, infant nutrition and animal feed.The world is striving for better nutrition. Nutrition which is less artificial and more natural, sustainable and cost effective - with a much higher nutritional value.At Nextferm, they aim to use their capabilities to lead this new and exciting world of better nutrition.
- iwi Life — Algae is the ultimate source of Omega-3s. Research has proven that Omega-3s support cardiovascular health, a balanced mood, and healthy brain development.
- The Mediterranean Food Lab — The Mediterranean Food Lab merge traditional fermentation and cutting-edge science, to produce natural plant-based flavor-bases for a wide range of meat replacement needs.
Alexandria Fund
Show more...Investment focus
- Industry: Biopharma, Life Science, Biotechnology
- Stage:Seed, Debt Financing
- Geography: Egypt
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Nawah Scientific — Nawah is MENA & Africa's first Cloud Lab providing R&D services to the region's scientific sectors.
Investing with conviction in visionary, technical founders inventing the future.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Biotechnology
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, Canada, Israel
Investor stats
- Total investments: 63
- Round size: Seed $1M–$7M; Pre-Seed $575k–$1.8M; Series A $4.2M–$15M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- iOrganBio — The Right Cells. Consistently. At Scale.
- Extellis — Reliable Satellite Imagery at an Industrial Scale
- Bedrock Energy — Bedrock Energy is developing drilling technology and advanced subsurface simulation software to enable geothermal heating and cooling. The company develops autonomous drilling technology and advanced subsurface simulation software to make geothermal heating and cooling more widespread, affordable, and accessible.
JVP is a top VC firm with $1.9B AUM and 165 companies built, leading in AI, Cyber Security, Fintech, Insurtech and Climatech.
Show more...Investment focus
- Industry: Software, Cyber Security, Enterprise Software
- Stage:Series A, Series B, Seed
- Geography: United States, Israel, United Kingdom
Investor stats
- Total investments: 191
- Round size: Seed $1.5M–$8M; Series A $4.3M–$24M; Series B $10M–$43M
- Lead/follow: 41% lead, 59% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Reduxio — Overcome data gravity with ionir, a Kubernetes Data Services platform built for enterprises and optimized to run in Kubernetes.
- ThetaRay — ThetaRay's big data analytics solutions are based on AI & machine learning, empowering businesses to find opportunities and threats hidden in their big data
- Altair Semiconductor — Altair is a fabless semiconductor company based in Israel that is developing state of the art, ultra low power mobile WiMAX silicon solutions optimized for handsets and handheld devices.Altair was founded in May 2005 by former Texas Instruments executives with extensive broadband and wireless silicon experience. Their products are thesmallest, lowest power solutions in the industry, offering superb mobility performance and enabling the migration of WiMAX from a fixed wireless PC technology to a true next generation mobile technology.Altair's management and technology executives were among the founding team of Libit Signal Processing, a fabless chip company acquired by Texas Instruments in 1999 for $365 million. The company's world class scientists, algorithm, VLSI and software engineers have in the past, jointly developed over twenty complex mixed-signal silicon products, spanning six different broadband wired and wireless technologies.Altair is a principal member of the WiMAX Forum and a member of the IEEE802.16e.
Healthcare innovation wherever it originates.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: United States, Israel, United Kingdom
Investor stats
- Total investments: 77
- Round size: Series A $5.9M–$63M; Series B $18M–$55M; Series C $300k–$100M
- Lead/follow: 30% lead, 70% follow
Portfolio highlights
- Moon Surgical — Create the OR of the future, one that is sustainable, efficient, and digitalized.
- Manus Neurodynamica — Manus Neurodynamica is a triage device to support early diagnostics in Parkinson's disease.
- Glyphic Biotechnologies — We sequence proteins. Glyphic Biotechnologies is decoding the human proteome through full coverage, de novo protein sequencing at single molecule resolution to enable the development of novel therapeutics and diagnostics and, ultimately, a deeper understanding of life itself.
RMGP Biopharma Investment Fund is an investment Fund
Show more...Investment focus
- Industry: Biotechnology, Biopharma, Life Science
- Stage:Seed, Series B
- Geography: Israel
Investor stats
- Total investments: 4
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Pi Therapeutics — Pi Therapeutics is a discovery-stage biopharmaceutical company aiming to develop a novel cancer drug. The company is financed by a syndicate of Takeda Pharmaceutical Company through its venture group Takeda Ventures Inc., Johnson & Johnson Innovation – JJDC, OrbiMed Israel Partners, Pontifax, and the Israel Innovation Authority, and hasoperated since March 2015 in the FutuRx biotech accelerator in Ness Ziona, Israel. The company’s mission is to develop novel first-in-class drugs directed against the ubiquitin-proteasome system (UPS), mainly for treatment of cancer.
- Skip Therapeutics — Skip Therapeutics develops precision, RNA-based, treatments for rare genetic diseases. Millions of people worldwide are affected by thousands of rare genetic disorders, yet the limited patient populations, further divided by patient-specific mutations, have hampered the discovery of effective treatments. Recent developments in RNA-therapeuticsprovide an enlarged molecular toolkit that can be used quickly and affordably to repair damaged genes' ability to make proteins. Computational techniques could be used to help identify sub-patient populations that would be eligible for treatment with RNA-based therapeutics and match molecular therapy options across the large landscape of known disease-causing mutations.
- Protekt Therapeutics — ProteKt Therapeutics is a drug development company aiming to develop potent and selective oral inhibitors of the kinase PKR for the treatment of neurodegenerative and neuroinflammatory diseases. The company has raised a $4M pre-A round and graduated from the FutuRx accelerator in 2019.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Ibtikar (Innovation, in Arabic) is a disruptive fund that will invest in innovative Palestinian companies. Ibtikar’s investments begin at the seed level through local accelerators, continue in post-acceleration phases and can also include series A investments in its portfolio companies. Through this investment strategy we aim to close a criticalfunding gap between acceleration and VC and other later-stage investors. Our goal is to maximize return for our investors by helping high-potential Palestinian companies answer regional and global needs. We will do this through direct support from our management team and select group of advisors, and will leverage the strong network of our investors and partners for the benefit of each of our portfolio companies.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, SaaS
- Stage:Seed, Pre-Seed, Series A
- Geography: Palestinian Territory, United States, Jordan
Investor stats
- Total investments: 36
- Round size: Seed $150k–$2M; Pre-Seed $60k–$750k
- Lead/follow: 64% lead, 36% follow
- Last fund: Likely still investing — raised $15M in 2022
Portfolio highlights
- Nabeeh — Nabeeh is an online platform that allows users to book housekeeping, cleaning services, maintenance, repairs, and renovation services.
- gamiphy — GAMIPHY is a user engagement and retention platform that equips brands in different industries with tools proven to increase customer reach and loyalty such as branded mini games, playable Ads and digital loyalty programs. The tools and techniques offered by GAMIPHY can be either integrated into existing websites and apps, or can be used to createplatform-independent solutions. The available solutions are diverse, fully customizable, DIY, and are guaranteed to improve each customer journey, thus shorten the path to earn the loyalty sought after.
- DataQueue — Discover essential strategies for AI readiness with DataQueue. Learn how to prepare your business, choose the right AI tools, and develop a strategic AI plan for future success
Pontifax is a healthcare-dedicated venture capital firm.The fund focuses on innovative bio-pharma opportunities.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Series A, Series B, Series C
- Geography: United States, Israel, France
Investor stats
- Total investments: 117
- Round size: Series A $6.3M–$110M; Series B $20M–$130M; Series C $12M–$101M
- Lead/follow: 24% lead, 76% follow
- Last fund: May invest from a new fund soon — raised $14M in 2020
Portfolio highlights
- ArQule — ArQule, Inc. is a clinical-stage biotechnology company engaged in the research and development of cancer therapeutics. The Company employs technologies, such as its ArQule Kinase Inhibitor Platform (AKIP) to design and develop drugs. The Company's product is ARQ 197, an orally administered inhibitor of the c-Met receptor tyrosine kinase. ARQ197 is being evaluated as monotherapy and in combination therapy in a Phase II clinical development program that includes trials in Microphthalmia Transcription Factor (MiT) associated tumors, non-small cell lung cancer (NSCLC), pancreatic adenocarcinoma and hepatocellular carcinoma (HCC). The Company has licensed commercial rights to ARQ 197 for human cancer indications to Daiichi Sankyo Co., Ltd. (Daiichi Sankyo) in the United States, Europe, South America and the rest of the world, excluding Japan and certain other Asian countries, where it has licensed commercial rights to Kyowa Hakko Kirin Co., Ltd. (Kyowa Hakko Kirin).
- Otic Pharma — Otic Pharma is a clinical-stage pharmaceutical company focusing on the development and commercialization of products for disorders of the ear, nose, and throat (ENT). The company has two platform technologies, each of which has the potential to be developed for multiple ENT indications. The company is currently developing anasally-administered, combination drug product (OP-02) intended to address the underlying cause of otitis media and Eustachian tube dysfunction (OM/ETD), a condition that affects more than 700 million people around the world every year. Otitis media is one of the most common disease seen in pediatric practice and the most frequent reason children consume antibiotics or undergo surgery. The company also has a foam-based drug delivery technology platform (OP-01) that can be used to deliver drugs into the ear, nose, and sinus cavities. The company is currently developing OP-01 as an improved treatment option for acute otitis externa (“swimmers ear”). For more information on the company, please visit www.oticpharma.com
- Applied Immune Technologies — Applied Immune Technologies Ltd. engages in development of therapeutic molecules for cancer, viral, and autoimmune diseases. The company develops T-Cell Receptor-Like (TCRL) antibodies that are targeted to intracellular-derived peptides for various therapeutic and diagnostic applications. Its TCRL antibodies also have diagnostic applications inpathology; and vaccine design, validation, and monitoring, as well as in the analysis of antigen presentation in disease. The company was formerly known as BioMimic Pharma. The company was founded in 2006 and is based in Haifa, Israel.
Backing a better tomorrow
Show more...Investment focus
- Industry: Renewable Energy, Energy, Software
- Stage:Series A, Seed, Series B
- Geography: Australia, United States, Singapore
Investor stats
- Total investments: 69
- Round size: Seed $808k–$10M; Series A $3.3M–$63M; Series B $26M–$151M
- Lead/follow: 26% lead, 74% follow
Portfolio highlights
- Endolith — Endolith is a biotech company transforming sustainable mining by leveraging microbes, synthetic biology, and cloud computing to extract more critical minerals like copper from low-grade ores. Working with the many of the leading mining companies, Endolith is advancing its innovative technology to commercial scale. Recognized as a finalist in theBHP Unearthed BioMetals cohort and a member of the Alaska Critical Minerals Collaborative, Endolith is driving the future of mining with sustainable, efficient, and responsible solutions for the clean energy transition.
- MAKO — Solving human problems with nature’s surfaces.
- Asterix Foods — Asterix Foods is a biotechnology company designed to build protein production using plant-cell culture techniques. The company's platform is developing and growing bioactive proteins for food that are scalable, functional, and complex, enabling users with plant cell-cultured and animal-free proteins.It was founded in 2022 and is located inTel Aviv, Israel.
Keiretsu Forum is a global angel investor network with more than 2,500 accredited investor members throughout 47 chapters on 3 continents.
Show more...Investment focus
- Industry: Health Care, Software, Biotechnology
- Stage:Seed, Series A
- Geography: United States, India, Turkey
Investor stats
- Total investments: 241
- Round size: Seed $85k–$3.3M; Series A $778k–$10M
- Lead/follow: 12% lead, 88% follow
- Last fund: May invest from a new fund soon — raised $10M in 2015
Portfolio highlights
- Bliss — Skip long waitlists and expensive therapy. Book licensed online therapists in multiple languages with culturally informed care.
- BatteryPool — BatteryPool offers battery charging solutions for EV fleets and commercial vehicles.
- Apriority Financial — Apriority Financial is a debt optimization platform that manages and optimizes employee personal debt.
The Scientific and Technological Research Council of Turkey (TÜBİTAK) is the leading agency for management, funding and conduct of research in Turkey. It was established in 1963 with a mission to advance science and technology, conduct research and support Turkish researchers. The Council is an autonomous institution and is governed by a ScientificBoard whose members are selected from prominent scholars from universities, industry and research institutions. TÜBİTAK is responsible for promoting, developing, organizing, conducting and coordinating research and development in line with national targets and priorities. TÜBİTAK acts as an advisory agency to the Turkish Government on science and research issues, and is the secretariat of the Supreme Council for Science and Technology (SCST), the highest S&T policy making body in Turkey.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Grant, Pre-Seed, Seed
- Geography: Turkey, United States, United Kingdom
Investor stats
- Total investments: 41
- Round size: Seed $50k–$161k; Grant $4k–$230k; Pre-Seed $30k–$521k
- Lead/follow: 34% lead, 66% follow
Portfolio highlights
- Navirid — Navirid is a technology company specializing in IoT and embedded systems, dedicated to developing advanced radar technologies and safety solutions to connect motorcyclists to life and enhance their riding experience.The radar-based systems we develop provide riders with real-time environmental awareness, establishing a new safety standard inmotorcycle use with critical features like blind spot detection, collision warning, and multi-target tracking.Our vision is to make motorcycles an integral part of the intelligent transportation ecosystem; our mission is to connect riders more firmly to life on every journey.
- VulnHero — AI-Driven Offensive Security | Attack Surface Management | Exploit Intelligence | Continuous Testing
- Viseur AI — Viseur AI delivers a cutting-edge medical imaging solution powered by artificial intelligence. Our platform provides robust, scalable, cost-effective long-term radiology and digital pathology solutions through end-to-end automation.
Trust Ventures is a venture capital firm that focuses on startups and provides knowledge and expertise in incumbent-heavy industries. The firm was founded in 2018 and is based in Austin, Texas, United States.
Show more...Investment focus
- Industry: Health Care, Software, Information Technology
- Stage:Seed, Series A, Series B
- Geography: United States, Brazil, Israel
Investor stats
- Total investments: 67
- Round size: Seed $3.2M–$23M; Series A $10M–$68M; Series B $9M–$200M
- Lead/follow: 25% lead, 75% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Fluxco — Procurement, leasing, service and warranty for padmount, substation, and distribution transformers from 100+ global suppliers.
- Base Power — Base provides a battery-powered home energy service so you can enjoy power without interruption and save money. Now available in select regions of Texas.
- Antora Energy — Antora converts low-cost, intermittent renewable electricity into a reliable, on-demand source of zero-emissions industrial heat and power.
Rationalwave Capital Partners is a venture capital firm investing in technology companies both public and private. The firm is located in New York and founded by Mark Rosenblatt in 2003.
Show more...Investment focus
- Industry: Analytics, Machine Learning, Artificial Intelligence
- Stage:Seed, Pre-Seed
- Geography: United States, Israel, Trinidad and Tobago
Investor stats
- Total investments: 12
- Round size: Seed $1.3M–$8.8M
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- Aromyx — Aromyx pioneers the creation of tastes and smells using a quantitative measurement system developed with biotechnology, data science, and AI.
- Brij — With one-touch, BRIJ allows consumers to gain product info, care instructions and discounts while you gain a deeper understanding of your consumer. Apps, paper manuals and hassles not required.
- BactoByte LTD — BactoByte aims to empower caregivers with one-hour bacterial diagnostics and antibiotic screening capability to improve outcomes, reduce mis-diagnostics, and lower health care costs.Based on a proprietary novel basic method, BactoByte’s assay delivers precise and cost-effective identification and direct antibiotics susceptibility testing with80-90% improvement of standard turnaround time.Time reduction, sensitivity, and specificity results in decreased mortality rates, fewer hospital days, and avoidance of associated costs of $1K-50K per patient.BactoByte has technology validation and partnerships with leading medical centers.
Joa Capital: Pioneers in financing technology and innovation in the Kingdom of Saudi Arabia.
Show more...Investment focus
- Industry: FinTech, Information Technology, Apps
- Stage:Seed, Series A, Pre-Seed
- Geography: United Arab Emirates, Saudi Arabia, Kuwait
Investor stats
- Total investments: 23
- Lead/follow: no public data
Portfolio highlights
- Prop-AI — Prop-AI is building the Bloomberg Terminal for real estate—an AI-powered platform that automates property discovery, evaluation, and acquisition.Headquartered in Dubai, Prop-AI uses proprietary machine learning and over 3 billion verified data points from government registries, real estate marketplaces, developers, and private sources. Itanalyzes all market listings and can access off-market opportunities by understanding all available supply and stakeholders. The platform delivers instant property valuations, investment scores, rental and appreciation forecasts, and fraud detection, giving investors and owners unmatched transparency and confidence.Prop-AI is focused on launching its Prop-AI Business platform and APIs for real estate professionals, alongside the region’s most advanced Agentic AI for Real Estate in 2025. These innovations aim to make intelligent, data-driven decision-making accessible to investors, real estate professionals, and eventually autonomous AI systems—setting a new standard for real estate investing in the region and beyond.
- Markopolo ai — Markopolo is a complete paid marketing suite that helps you launch targeted ads in seconds. Generate the perfect creative and AI-powered copy, schedule posts ahead of time to save time and get real-time analytics on how well they perform! If you’re looking for a smarter, faster way to create ads and automate the boring parts of ad management,there’s a tool you need to meet.We have built the software for cookieless era. We use server side pixel to gather lossless data from each and every attribution point. Business that adopt Markopolo see 34% reduction in Cost per click, 41% increase in Conversion rate and 30% increase in Budget spending efficiency within first few campaigns. These are the benchmarks achieved with the algorithms behind Marokopolo, and we have just started! We provide an end to end solution in Paid Marketing, which is critical for a modern marketing team manager to improve efficiency. Finding the right audience to target is a complicated science that we have cracked at Markopolo. We have a patent pending status in USPTO on it. Lastly getting real-time analytics from all these platforms and actionable suggestions from Markopolo algorithm completes the whole user journey.Features: - Integrates with Facebook, Instagram, Google Ads and YouTube - Built in Campaign Manager for scheduling and managing all the ads from one place - Ad Engine that monitors and optimises all the Ads 24/7 - Suggestion Engine that guides like a professional marketer - Get a holistic overview of all the metrics from all the campaigns in one dashboard - Ad Maker that comes with AI Generated Copy and Creatives - Targeting AI generates custom Audience presets - GDPR Compliant1,000+ businesses use Markopolo to automate their campaign creation and management in Social and Search Ad platforms.Try us out- https://www.markopolo.ai/Watch our product demo- https://www.youtube.com/watch?v=0VExF-j9sdg&t=87sWatch this how to get started video series- https://www.youtube.com/watch?v=VyFsYkb4YvQ&list=PLG1FKDs4H_wGH0NfxNflJgr0WVzn6m8Pj
- medIQ — Do you need stress-free employee healthcare funds management services? Then MedIQ is here to provide you with the best cost-effective services. Reach us Today!
Sectoral is specialized in managing equities globally in the healthcare sector. Founded in October 2000, we are SEC-registered as an investment advisor. 100% employee-owned, we have offices in Montreal, Geneva, and Hong Kong.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series C, Post-IPO Equity
- Geography: United States, United Kingdom, France
Investor stats
- Total investments: 48
- Lead/follow: no public data
Portfolio highlights
- CurvaFix — Curvafix is the only intramedullary implant that follows the natural curvature of the pelvis. Continue reading to learn how the Curvafix implant works!
- Boundless Bio — Boundless Bio is a company that develops novel cancer therapeutics intended to understand and treat intraceable cancers. It aims to be the foremost biopharma company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with previously intractable cancers.Boundless Bio was founded in 2018 and isheadquartered in La Jolla, California.
- LENZ Therapeutics — LENZ Therapeutics is a late-stage clinical company developing innovative ophthalmic pharmaceutical products that improve vision.
Clal Biotechnology Industries is a leading Israeli life sciences investment company traded on the Tel Aviv Stock Exchange (TASE: CBI).
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B
- Geography: Israel, United States
Investor stats
- Total investments: 15
- Round size: Series A $4M–$55M; Series B $15M–$33M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- TytoCare — TytoCare offers the Home Smart Clinic - for accessible, high-quality primary care from home, with no compromises.
- Sight Diagnostics — Combining AI and breakthrough hardware to bring lab-quality CBC results to the doctor's office.
- Cadent Therapeutics — Cadent Therapeutics is a precision neuroscience company developing novel medicines that tune and modulate brain rhythms to restore cognitive and motor function in patients with serious neurological disease. The company leverages its precision neuroscience approach combining target specificity, patient selection, drug design and optimization, andnovel quantitative endpoints to create first-in-class molecules to treat movement and cognitive disorders.It was founded in 2010 and headquartered in Cambridge, Massachusetts.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Angel
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Pre-Seed, Seed, Series A
- Geography: United States, United Kingdom, Singapore
Investor stats
- Total investments: 61
- Lead/follow: no public data
Portfolio highlights
- Vytal.ai — Vytal allows for brain health evaluation in minutes with just a laptop. Take control of your cognitive health.
- Akhetonics — Creating the first all-optical RISC Processor
- Greena World — In a world where travel connects us, we often overlook the impact we leave behind. Tourism accounts for over 8% of global CO2 emissions. Beyond environmental challenges like deforestation, pollution, and water scarcity, local communities also face pressure, experiencing changes in their traditions and ways of life.With expertise from SwanseaUniversity and the United Nations, our team recognised these challenges and envisioned a world where travel helps, not harms. Introducing Greena World. More than just a piece of technology, it's a guide for hotels and restaurants, helping them understand, improve, and share their impact on both the environment and local communities.The true beauty of embracing sustainability? The rewards. With the Greena Index, businesses can improve their sustainability and, in doing so, unlock a new market of over 100+ million eco-conscious travellers, boost revenues, and save on operating costs.The sustainable tourism sector is rapidly expanding, currently valued at $75B and witnessing a growth rate of 9.7% each year. While our initial focus is on hotels and restaurants, the Greena Index has ambitions to reshape the entire spectrum of the industry, from airlines to activities and destinations.Join us on a mission to transform the entire tourism industry for many generations to come.
The Land of Milk and Honey is an abundant location where life is simple and devoid of need. Both in brand-new real estate development projects and while professionally restoring and renovating houses, Milk and Honey Investments LLC aims to create distinctive spaces of abundance and healthy living.
Show more...Investment focus
- Industry: Life Science, Organic Food, Biotechnology
- Stage:Series A
- Geography: Israel
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- BioBetter — BioBetter is a foodtech company that develops plant-based platforms for the production of complex growth factors used in cultivated meat. The company was founded in 2015 and is headquartered in Israel.
A Diversified Company focused on multiple area of the cannabis hemp and CBD industry.
Show more...Investment focus
- Industry: AgTech, Medical, Cannabis
- Stage:Series A
- Geography: Israel
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- GemmaCert — GemmaCert is a smart solution for testing cannabis potency, which unlike other solutions, is simple and sleek, for everyday use, requiring no specific skill-set for operation, and whose form gives little indication to the sophistication of the technology working underneath. GemmaCert is a bridge between technology and nature. This design createdthe desired attractive and useful man-machine interface for the best possible user experience along with a well-defined product with aesthetic presence without sacrificing on performance. GemmaCert is making a name for high performance, robustness, ease-of-use and reliability.No cannabis flower is the same, so before anyone consumes cannabis, they should have an understanding exactly what is in it and how it may affect them. From pharmacies in Germany, coffeeshops in Amsterdam, to supply chain stakeholders in North America, GemmaCert brings certainty and confidence to cannabis professionals, as well as consumers and patients worldwide.After over two years in research and development, GemmaCert started delivering first units to customers worldwide, primarily in North America and Europe. Revenues are generated from device sales and monthly subscription fees to our analytical service since GemmaCert units are operated and upgraded via secure cloud-based servers.
An investment banking boutique, founded in 1978
Show more...Investment focus
- Industry: AgTech, Medical, Cannabis
- Stage:Series A
- Geography: Israel
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- GemmaCert — GemmaCert is a smart solution for testing cannabis potency, which unlike other solutions, is simple and sleek, for everyday use, requiring no specific skill-set for operation, and whose form gives little indication to the sophistication of the technology working underneath. GemmaCert is a bridge between technology and nature. This design createdthe desired attractive and useful man-machine interface for the best possible user experience along with a well-defined product with aesthetic presence without sacrificing on performance. GemmaCert is making a name for high performance, robustness, ease-of-use and reliability.No cannabis flower is the same, so before anyone consumes cannabis, they should have an understanding exactly what is in it and how it may affect them. From pharmacies in Germany, coffeeshops in Amsterdam, to supply chain stakeholders in North America, GemmaCert brings certainty and confidence to cannabis professionals, as well as consumers and patients worldwide.After over two years in research and development, GemmaCert started delivering first units to customers worldwide, primarily in North America and Europe. Revenues are generated from device sales and monthly subscription fees to our analytical service since GemmaCert units are operated and upgraded via secure cloud-based servers.
Hadasit Bio-Holdings Ltd. ("HBL") was founded and floated on the Tel Aviv Stock Exchange (TASE : HDST ) and recently on the OTC (OTCBB : HADSY ) in order to allow public participation in the highly promising field of biotechnology.It serves as a precedent in biotech financing - for the first time, public investment is allowed toparticipate in a holding entity including companies based on IP generated by Israel’s foremost medical research center – Hadassah University Hospital ("HU").In addition to the public holdings (54%) – including major Israeli institutional investors, HBL is held by Hadasit (www.hadasit.co.il) (36%) and Consensus Business Group (http://www.consensusbusiness.com) (10%). The traded stock, as a unique investment vehicle, provides investment exposure to a select cluster of 6 biotech companies - all based on inventions developed and owned by HU.HBL is a publicly traded subsidiary of Hadasit Ltd. – the technology transfer company of the Hadassah University Hospital in Jerusalem, Israel. Hadasit was established for the purpose of promoting and commercializing the intellectual property (IP) and R&D capabilities generated by Hadassah, aimed at finding solutions to problems faced by modern medicine.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Series A, Series B
- Geography: Israel
Investor stats
- Total investments: 9
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- ProtAb — ProtAb develops therapeutic agents that modulate cytokine regulation, tipping the balance toward anti-inflammatory signaling pathways in the treatment of autoimmune and inflammatory diseases. Its first product, Prozumab, is a monoclonal antibody with a novel mechanism of action. It is currently in late-stage preclinical development for thetreatment of inflammatory bowel disease or IBD, ulcerative colitis or UC, and rheumatoid arthritis or RA. It operates as a subsidiary of Hadasit Bio-Holdings. HBL is a publicly traded subsidiary of Hadasit, the technology transfer company of the Hadassah University Hospital in Jerusalem in Israel.
- KAHR medical — KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment optionsfor cancer and autoimmune disorders.
- Enlivex Therapeutics — Enlivex is a clinical-stage macrophage reprogramming immunotherapy company that targets diseased macrophages in patients with sepsis. The company develops an autologous and allogeneic drug pipeline for the treatment of autoimmune and inflammatory conditions such as Graft versus Host Disease (GvHD), solid organ transplant rejection, Crohn'sDisease, and other autoimmune and inflammatory disorders.The company's revolutionary approach is to induce immune tolerance by injecting apoptotic cells and facilitating their interaction with dendritic cells activates the body's innate, physiologic mechanism for down-regulating inflammation and autoimmunity.Enlivex is an Israeli-based cell immunotherapy company established in October 2005 by Professor Dror Mevorach, a world-renowned expert on clearance of dying (apoptotic) cells.
Discover Boehringer Ingelheim Venture Fund. We invest in groundbreaking science to transform care. Explore our mission and join us in advancing medicine
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: United States, Germany, Switzerland
Investor stats
- Total investments: 100
- Round size: Seed $1.8M–$20M; Series A $3.8M–$34M; Series B $11M–$50M
- Lead/follow: 48% lead, 52% follow
- Last fund: May invest from a new fund soon — raised $250M in 2018
Portfolio highlights
- Perfood — Perfood is a digital therapeutic startup that identifies what actions need to take on a personalized level, to prevent or fight diseases. Using sensors, lab results, and holistic analyses, they derive therapeutic angles and deliver them in a slick, easy-to-use way, making them accessible for all patients. They call this approach digitaltherapeutics. A digital solution that is just as effective as a drug. But without side effects.
- ArrePath — ArrePath is an anti-infective drug discovery company addressing the global health challenge of drug resistant infections.
- Brainomix — Since launching as a spin-out from the University of Oxford in 2010, Brainomix has developed award-winning, AI-powered imaging biomarkers, assisting physicians across the world to make better life-saving decisions. Brainomix seminal product, e-Stroke is a collection of tools that use state-of-the-art AI algorithms to support doctors by providingreal-time interpretation of brain scans to help guide treatment and transfer decisions for stroke patients, allowing more patients to get the right treatment, in the right place, at the right time.
Khwarizmi Ventures is a venture capital firm that seeks investments in startups with a passion for algorithms. It seeks to help create their vision, as they embark on a journey together that aligns their goals to improve quality of life using technology powered by algorithms. .
Show more...Investment focus
- Industry: E-Commerce, Software, FinTech
- Stage:Seed, Series A, Pre-Seed
- Geography: Saudi Arabia, United Arab Emirates, Egypt
Investor stats
- Total investments: 56
- Lead/follow: no public data
Portfolio highlights
- Calo — Analyze your nutritional needs and subscribe to a convenient meal plan that's designed for you in under 2 minutes.
- Buildnow — BuildNow is MENAP's first "Build Now Pay Later" solution. We fund the raw materials construction & manufacturing SMEs need, while providing credit terms tailored to optimize their cash flow and supercharge their growth.
- Mala'a Technologies — Make better financial decisions with Malaa. Manage your financials, track your expenses, take a loan or invest your money all from one app. Connect you bank accounts and start today
Based out of Dubai, Knuru pursues equity and credit opportunities in fintech and marketplaces across the GCC, Africa and Southern Europe. The management is led by a team of investors and entrepreneurs bringing to venture capital extensive cross-asset class experience dedicated to supporting high growth businesses.
Show more...Investment focus
- Industry: E-Commerce, Information Technology, Financial Services
- Stage:Series A, Series C
- Geography: United Arab Emirates, Spain, Kenya
Investor stats
- Total investments: 10
- Lead/follow: no public data
Portfolio highlights
- Savana — Electronic Health Records reuse, with Clinical Natural Language Processing.
- Alma Health — Alma Health is a digitally-native chronic illness management platform serving an addressable market of 20m patients in GCC. Through its cloud pharmacy and virtual doctor consultations, Alma Health is translating patient behavior and insights into personalized services and products like digital treatments and at home monitoring systems. Alma Healthis based in Hub71-Abu Dhabi.
- The Giving Movement — Sustainable Activewear & Streetwear Clothing | Made in UAE | $4 per item donated to charity | Gym Clothing & Workout Clothes
Pfizer provides access to safe and effective and affordable medicines and health care services. They have a portfolio of products and medicines that support wellness and prevention, as well as treatment and cures for diseases across a broad range of therapeutic areas; and they have an industry-leading pipeline of promising new products that havethe potential to challenge some of the most feared diseases of their time, like Alzheimer's disease and cancer.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Post-IPO Equity, Series A, Seed
- Geography: United States, Israel, France
Investor stats
- Total investments: 53
- Lead/follow: no public data
Portfolio highlights
- CytoReason — CytoReason is a tech company developing a computational model of the human body. The company collects proprietary data from pharma companies and uses it to simulate human diseases – tissue by tissue, cell by cell. With CytoReason’s massive database and AI-led platform, pharma and biotech companies identify new opportunities, shorten trial phases,reduce development costs and increase the likelihood of approval. To date, six of the world’s top ten pharma companies use CytoReason’s technology.
- AgomAb Therapeutics — AgomAb is developing molecular therapies for the regeneration of damaged tissues. Their unique agonistic monoclonal antibody molecules (“agomAbs”) stimulate molecular and cellular repair mechanisms that have the potential to restore organ function in patients with fibrotic, inflammatory, autoimmune and degenerative diseases.
- EvolveImmune Therapeutics — EvolveImmune Therapeutics transforms the discovery and development of novel immunotherapies. By leveraging its proprietary in vivo target discovery platform, EvolveImmune is building a pipeline of novel therapeutic candidates against numerous targets that are expressed on multiple immune cell types. The company’s platform will generatefirst-in-class treatments for unmet needs in oncology and autoimmune diseases.
Khosla Ventures is a venture capital firm that invests in early- to late-stage companies across sectors like AI, healthcare, sustainability, and consumer technology. It manages multiple funds, focusing on startups with innovative technologies or business models. The firm primarily targets sectors like AI, climate tech, digital health, and medtech,offering strategic support to help build long-lasting companies.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Series A, Series B, Seed
- Geography: United States, India, United Kingdom
Investor stats
- Total investments: 981
- Lead/follow: no public data
Portfolio highlights
- Periodic Labs — Periodic Labs develops artificial intelligence systems that simulate and predict the properties of materials using machine learning. The company applies computational models to support the discovery and design of materials used in sectors such as energy, electronics, and infrastructure. It builds tools that aim to reduce the time and costassociated with traditional research and development processes. Periodic Labs uses AI to analyze large-scale scientific data and collaborates with academic and industry partners to support material science research.
- Vectra AI — Vectra is the world leader in AI threat detection and response. The Cognito platform uses AI to detect attackers in real time and perform conclusive investigations.
- Point One Navigation — Precise Positioning for the next generation of transportation. 10cm accuracy everywhere.
FAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Life Science VC Funds in Middle East investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 48,091 VC funds investing in Middle East Life Science startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!